Form 4: HeartBeam Director Strome Granted 41,380 Options

HeartBeam, Inc. Director and 10% Owner Mark E. Strome was granted 41,380 stock options with an exercise price of $1.43, vesting in two tranches.

Summary

• Mark E. Strome, a Director and 10% Owner of HeartBeam, Inc., was granted 41,380 options to purchase common stock.
• The options, referred to as the 'Special Option', have an exercise price of $1.43 per share.
• The vesting commencement date for these options was January 1, 2026.
• One half of the total options (20,690 shares) will vest on March 31, 2026, which is the three-month anniversary of the vesting commencement date.
• The remaining half of the options (20,690 shares) will vest on June 30, 2026, the six-month anniversary of the vesting commencement date.
• These options were issued from the Company's 2022 Equity Incentive Plan.
• The options expire on January 1, 2036.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, as it signifies continued alignment of a key insider's interests with the company's long-term performance through equity compensation, which is a standard corporate governance practice.

Positives

• The grant of stock options to a Director and 10% Owner aligns insider interests with long-term shareholder value creation.

Future Outlook

The future outlook related to this filing primarily concerns the vesting of the granted options, with half vesting on March 31, 2026, and the remainder on June 30, 2026, aligning the director's incentives with future company performance.

Industry Context

StockSavvy.ai notes that the grant of stock options to key insiders like directors is a common practice across industries, particularly in growth-oriented companies. This mechanism is widely used to incentivize long-term performance and align the interests of management and significant shareholders with those of the broader investor base. Such grants are typically part of a company's overall compensation strategy to attract and retain talent.

Corporate Governance

Stakeholder Impact

• Shareholders benefit from increased alignment of Director Mark E. Strome's interests with the company's long-term performance and stock value through the equity grant.

Next Steps

• Vesting of 20,690 shares of common stock on March 31, 2026.
• Vesting of 20,690 shares of common stock on June 30, 2026.

Key Dates

Keywords

HeartBeam, BEAT, Stock Options, Insider Transaction, Form 4, Equity Incentive Plan, Director Compensation, Mark E. Strome